-
Mashup Score: 0
Among 287 patients across multiple solid tumor indications, YL201 had an objective response rate of 40.8%, with a disease control rate of 83.6%.
Source: www.cancernetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 0
The liposomal formulation of gemcitabine may enhance anti-tumor activity by increasing plasma half-life and improving targeted delivery to tumors.
Source: www.cancernetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 4The OncFive: Top Oncology Articles for the Week of 6/29 - 2 day(s) ago
The FDA grants approval to sunvozertinib in NSCLC and linvoseltamab in myeloma and removes REMS requirements for approved CAR T-cell therapies.
Source: www.onclive.comCategories: General Medicine NewsTweet
-
Mashup Score: 2
ATR04-484 showed inhibition of both methicillin-sensitive and methicillin-resistant Staphylococcus aureus bacteria strains, which are associated with rash.
Source: www.cancernetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 3Padeliporfin Vascular Targeted Photodynamic Therapy Safely Produces High Response Rates in Low-Grade Upper Tract Urothelial Cancer - 3 day(s) ago
Padeliporfin vascular targeted photodynamic therapy was highly active with a tolerable safety profile in low-grade upper tract urothelial cancer.
Source: www.onclive.comCategories: General Medicine NewsTweet
-
Mashup Score: 4
Cancer parametric PET imaging with radioactive tracers is reduced from an hour to 20 minutes
Source: www.onclive.comCategories: General Medicine NewsTweet
-
Mashup Score: 0
A WeCanWork study showed that men who work laborious jobs need additional support during and after cancer treatment.
Source: www.cancernetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 4
PATHFINDER 2 data build upon bolstered cancer detection rates by the multi-cancer early detection test found in a previously published PATHFINDER study.
Source: www.cancernetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 268Ga-FAPI-46 PET Acts as Biomarker for FAP-Positive Cancers - 4 day(s) ago
68Ga-FAPI-46 PETâs SUVpeak was highest in patients with pancreaticobiliary cancer, sarcoma, lung cancer, and esophageal/gastrointestinal cancer.
Source: www.cancernetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 15Improving the Alliance Between Oncologists and Primary Care Providers: A Call for Collaborative Action - 4 day(s) ago
Experts and patients alike would agree that navigating the current fragmented U.S. health-care system is not an easy task. One component of that disconnection may center on the relationship between on…
Source: ascopost.comCategories: General Medicine NewsTweet
YL201, a B7H3-targeting ADC, demonstrated an acceptable safety profile and early efficacy in patients with advanced solid tumors previously treated with at least 1 standard therapy. #oncology https://t.co/AhPTVLImKG